A

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Vice President, CMC Strategy

Regulatory & Quality (Life Sciences)Posted on Nov 10
Full-timeRemote in USA

About the Job

Requirements

  • An advanced degree in chemistry, chemical engineering, pharmaceutical sciences, or a related scientific discipline is required.
  • At least 15 years of progressive pharmaceutical or biotechnology CMC experience is required, including significant leadership overseeing complex development programs and global CMC activities across the full product lifecycle.
  • Experience leading CMC organizations, developing organizational capabilities, and managing high-performing teams is required.
  • Extensive experience developing and executing global CMC strategies across preclinical, clinical, and commercial-stage programs, including CMC asset leadership and program team representation, is required.
  • A proven track record leading successful global regulatory submissions, product approvals, and commercial readiness activities is required.
  • A strong understanding of global CMC regulatory requirements, including FDA, EMA, PMDA, ICH, and applicable cGMP standards, is required.
  • Expertise in CMC lifecycle management, including post-approval changes, global market expansion, comparability strategy, and regulatory commitments, is required.
  • Experience leading complex cross-functional programs and partnering with Technical Development, MSAT, External Manufacturing, Regulatory Affairs, Quality, and Supply Chain is required.
  • Strong business acumen and the ability to translate scientific, regulatory, and operational considerations into strategic business decisions are required.
  • The ability to establish priorities, manage competing demands, anticipate risks, and drive execution across multiple programs is required.
  • The ability to work effectively in a dynamic, growing biotechnology organization and balance strategic priorities with operational execution is required.
  • The ability to travel internationally up to 10% is required.

Responsibilities

  • Develop and lead integrated CMC strategies across the preclinical, clinical, and commercial portfolio, aligning them with corporate objectives and asset development plans.
  • Provide strategic oversight of CMC activities from early development through late-stage clinical programs, regulatory approval, commercialization, and lifecycle management.
  • Establish portfolio-level priorities, resource-allocation strategies, and risk-mitigation plans across multiple programs.
  • Partner with cross-functional leadership to ensure CMC strategies support clinical development milestones, regulatory commitments, and commercial readiness.
  • Anticipate and address CMC challenges, dependencies, and risks that could affect development timelines, regulatory approvals, or product supply.
  • Represent CMC in portfolio governance, asset leadership, and strategic planning discussions, and drive alignment and decision-making across CMC functions.
  • Translate asset objectives into phase-appropriate, risk-based integrated CMC plans, securing functional alignment, resources, and budgets for execution.
  • Partner with Regulatory Affairs, Quality, and technical functions to meet evolving CMC regulatory requirements across the United States, Europe, Japan, and other international markets.
  • Provide strategic oversight of CMC components of INDs, NDAs, MAAs, and other global regulatory submissions, including health-authority responses and post-approval commitments.
  • Plan and coordinate global CMC readiness activities required to support clinical development, regulatory approvals, and commercial launches.
  • Oversee strategic planning and coordination of CMC-related regulatory changes, commitments, and implementation activities across global markets.
  • Establish governance, risk-management, and decision-making processes for timely execution of global CMC priorities.
  • Collaborate with program teams and cross-functional stakeholders to align CMC deliverables with program timelines and business objectives.
  • Develop and oversee CMC lifecycle-management strategies supporting product sustainability, global expansion, and long-term commercial objectives.
  • Lead strategic planning for post-approval CMC activities, including manufacturing changes, site transfers, capacity expansion, and regulatory variations, with the responsible technical and manufacturing functions.
  • Partner with Program Teams, Commercial, Supply Chain, and Regulatory Affairs to support geographic expansion and evolving market requirements.
  • Ensure lifecycle-management plans anticipate regulatory changes, supply needs, and business priorities; drive alignment on lifecycle priorities, investment decisions, and execution timelines.
  • Provide strategic oversight of lifecycle initiatives to ensure effective implementation, regulatory compliance, and continuity of supply.
  • Lead, mentor, and develop the CMC organization, including CMC asset leaders and program-management professionals, establishing priorities, accountability, and performance expectations.
  • Build organizational capabilities and ensure the team is structured and resourced to support an expanding global pipeline and commercial portfolio.
  • Provide leadership and oversight to CMC asset teams, promoting collaboration, operational excellence, and effective decision-making.
  • Foster a high-performing culture focused on scientific rigor, strategic thinking, accountability, and continuous improvement.
  • Develop talent, strengthen succession planning, and support the professional growth of CMC team members.
  • Partner with senior leadership on organizational planning, workforce needs, and long-term capability development.
  • Promote cross-functional partnerships and effective communication and coordination across CMC functions.
  • Partner with Technical Development, MSAT, Regulatory Affairs, Quality, Supply Chain, External Manufacturing, R&D, Clinical Development, Program Management, and Commercial teams.
  • Establish CMC governance, program oversight, and performance-management processes for consistent portfolio execution.
  • Oversee CMC program timelines, budget assumptions, and critical milestones, ensuring transparency, accountability, and timely escalation of risks.
  • Partner with technical and manufacturing leaders to align development, manufacturing, and supply strategies with asset and portfolio objectives.
  • Drive continuous improvement in CMC planning, execution, communication, and cross-functional collaboration.
  • Represent CMC in senior leadership discussions, providing recommendations on strategic priorities, risks, investments, and business decisions.
  • Integrate CMC activities across functions to support timely achievement of program milestones.

Desired Qualifications

  • Experience with both large- and small-molecule pharmaceutical development and manufacturing is preferred.

About the Company

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with a focus on ALS and Alzheimer's disease. Its main asset is AMX0035, currently in clinical trials, including the CENTAUR study for ALS and the PEGASUS study for late mild cognitive impairment or early dementia due to Alzheimer’s disease. The company advances products through rigorous, randomized, double-blind, placebo-controlled trials to demonstrate safety and efficacy before pursuing commercialization. In addition to research, Amylyx engages in awareness and community campaigns to support patients, caregivers, and researchers. The company aims to bring validated therapies to market to improve patient outcomes and generate revenue by selling treatments to healthcare providers and patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Amylyx Pharmaceuticals

See more jobs